Ingevity (NYSE:NGVT – Get Free Report) is anticipated to announce its earnings results after the market closes on Tuesday, February 18th. Analysts expect the company to announce earnings of $0.29 per share and revenue of $297.40 million for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.
Ingevity Price Performance
Ingevity stock opened at $45.01 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 6.52. The stock has a market cap of $1.64 billion, a P/E ratio of -2.90 and a beta of 1.64. The company has a 50-day moving average price of $43.34 and a 200 day moving average price of $40.91. Ingevity has a 12-month low of $30.90 and a 12-month high of $56.29.
Wall Street Analyst Weigh In
Separately, BMO Capital Markets upped their price objective on Ingevity from $40.00 to $47.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $52.17.
About Ingevity
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
See Also
- Five stocks we like better than Ingevity
- What Does Downgrade Mean in Investing?
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- The Risks of Owning Bonds
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- What to Know About Investing in Penny Stocks
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.